AGILE THERAPEUTICS INC Annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Agile Therapeutics Inc annual/quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from 2018 to 2023.
  • Agile Therapeutics Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending December 31, 2022 was -$3.93M, a 79.9% increase year-over-year.
  • Agile Therapeutics Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending December 31, 2022 was -$25.4M, a 64.2% increase year-over-year.
  • Agile Therapeutics Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was -$14.5M, a 43.1% increase from 2022.
  • Agile Therapeutics Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$25.4M, a 64.2% increase from 2021.
  • Agile Therapeutics Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$71.1M, a 37.1% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$14.5M +$10.9M +43.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$25.4M +$45.7M +64.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$71.1M -$19.2M -37.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 -$51.9M -$33.2M -179% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 -$18.6M +$1.17M +5.93% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
2018 -$19.8M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.